Cargando…
Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
Acquired resistance toward apoptosis represents one of the hallmarks of human cancer and a major cause of the inefficacy of most anticancer treatment regimens. Based on its ability to inhibit apoptosis, the B-cell lymphoma/leukemia 2 (Bcl-2) protein family has garnered the most attention as a promis...
Autores principales: | Brinkmann, K, Kashkar, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973243/ https://www.ncbi.nlm.nih.gov/pubmed/24603326 http://dx.doi.org/10.1038/cddis.2014.61 |
Ejemplares similares
-
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine
por: Ferrarini, Isacco, et al.
Publicado: (2022) -
Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy
por: Albert, Marie-Christine, et al.
Publicado: (2014) -
Mitochondrial transfer in hematological malignancies
por: Guo, Xiaodong, et al.
Publicado: (2023) -
Targeting DNA Repair Pathways in Hematological Malignancies
por: Alhmoud, Jehad F., et al.
Publicado: (2020) -
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
por: Sorrentino, Claudia, et al.
Publicado: (2019)